<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2020-10-07" version="229">
<accession>Q15796</accession>
<name>SMAD2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mothers against decapentaplegic homolog 2</fullName>
<shortName>MAD homolog 2</shortName>
<shortName>Mothers against DPP homolog 2</shortName>
</recommendedName>
<alternativeName>
<fullName>JV18-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Mad-related protein 2</fullName>
<shortName>hMAD-2</shortName>
</alternativeName>
<alternativeName>
<fullName>SMAD family member 2</fullName>
<shortName>SMAD 2</shortName>
<shortName>Smad2</shortName>
<shortName>hSMAD2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SMAD2</name>
<name type="synonym">MADH2</name>
<name type="synonym">MADR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="347" last="349">
<title>Mad-related genes in the human.</title>
<authorList>
<person name="Riggins G.J."/>
<person name="Thiagalingam S."/>
<person name="Rosenblum E."/>
<person name="Weinstein C.L."/>
<person name="Kern S.E."/>
<person name="Hamilton S.R."/>
<person name="Willson J.K.V."/>
<person name="Markowitz S.D."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B.V."/>
</authorList>
<dbReference type="PubMed" id="8673135"/>
<dbReference type="DOI" id="10.1038/ng0796-347"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>VARIANT 344-GLU--GLN-358 DEL</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Nature" volume="383" first="168" last="172">
<title>Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Feng X.-H."/>
<person name="Wu R.-Y."/>
<person name="Derynck R."/>
</authorList>
<dbReference type="PubMed" id="8774881"/>
<dbReference type="DOI" id="10.1038/383168a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Cell" volume="86" first="543" last="552">
<title>MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.</title>
<authorList>
<person name="Eppert K."/>
<person name="Scherer S.W."/>
<person name="Ozcelik H."/>
<person name="Pirone R."/>
<person name="Hoodless P."/>
<person name="Kim H."/>
<person name="Tsui L.-C."/>
<person name="Bapat B."/>
<person name="Gallinger S."/>
<person name="Andrulis I.L."/>
<person name="Thomsen G.H."/>
<person name="Wrana J.L."/>
<person name="Attisano L."/>
</authorList>
<dbReference type="PubMed" id="8752209"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80128-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
<scope>PHOSPHORYLATION BY TGFBR1</scope>
<scope>VARIANTS CYS-133; ARG-440; HIS-445 AND GLU-450</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="3157" last="3167">
<title>Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.</title>
<authorList>
<person name="Liu F."/>
<person name="Pouponnot C."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9389648"/>
<dbReference type="DOI" id="10.1101/gad.11.23.3157"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Genomics" volume="48" first="1" last="11">
<title>Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway.</title>
<authorList>
<person name="Takenoshita S."/>
<person name="Mogi A."/>
<person name="Nagashima M."/>
<person name="Yang K."/>
<person name="Yagi K."/>
<person name="Hanyu A."/>
<person name="Nagamachi Y."/>
<person name="Miyazono K."/>
<person name="Hagiwara K."/>
</authorList>
<dbReference type="PubMed" id="9503010"/>
<dbReference type="DOI" id="10.1006/geno.1997.5149"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS LONG AND SHORT)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Pancreas</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="von Kriegsheim A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-14 AND 170-182</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Chronic myeloid leukemia cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Cell" volume="87" first="1215" last="1224">
<title>MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.</title>
<authorList>
<person name="Macias-Silva M."/>
<person name="Abdollah S."/>
<person name="Hoodless P.A."/>
<person name="Pirone R."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="8980228"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81817-6"/>
</citation>
<scope>INTERACTION WITH TGFBR1</scope>
<scope>PHOSPHORYLATION AT SER-464; SER-465 AND SER-467</scope>
<scope>MUTAGENESIS OF SER-464; SER-465 AND SER-467</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Cell" volume="95" first="779" last="791">
<title>SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.</title>
<authorList>
<person name="Tsukazaki T."/>
<person name="Chiang T.A."/>
<person name="Davison A.F."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="9865696"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81701-8"/>
</citation>
<scope>INTERACTION WITH ZFYVE9</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="4056" last="4065">
<title>Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.</title>
<authorList>
<person name="Kawabata M."/>
<person name="Inoue H."/>
<person name="Hanyu A."/>
<person name="Imamura T."/>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="9670020"/>
<dbReference type="DOI" id="10.1093/emboj/17.14.4056"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="703" last="709">
<title>Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3.</title>
<authorList>
<person name="Yagi K."/>
<person name="Goto D."/>
<person name="Hamamoto T."/>
<person name="Takenoshita S."/>
<person name="Kato M."/>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="9873005"/>
<dbReference type="DOI" id="10.1074/jbc.274.2.703"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS LONG AND SHORT)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="984" last="995">
<title>The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.</title>
<authorList>
<person name="Kretzschmar M."/>
<person name="Liu F."/>
<person name="Hata A."/>
<person name="Doody J."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9136927"/>
<dbReference type="DOI" id="10.1101/gad.11.8.984"/>
</citation>
<scope>PHOSPHORYLATION AT SER-465 AND SER-467</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27678" last="27685">
<title>TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.</title>
<authorList>
<person name="Abdollah S."/>
<person name="Macias-Silva M."/>
<person name="Tsukazaki T."/>
<person name="Hayashi H."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="9346908"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27678"/>
</citation>
<scope>PHOSPHORYLATION AT SER-465 AND SER-467 BY TGFBR1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Mol. Cell" volume="2" first="121" last="127">
<title>Characterization of human FAST-1, a TGF beta and activin signal transducer.</title>
<authorList>
<person name="Zhou S."/>
<person name="Zawel L."/>
<person name="Lengauer C."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
</authorList>
<dbReference type="PubMed" id="9702198"/>
<dbReference type="DOI" id="10.1016/s1097-2765(00)80120-3"/>
</citation>
<scope>INTERACTION WITH FOXH1</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="15" last="23">
<title>Roles of pathway-specific and inhibitory Smads in activin receptor signaling.</title>
<authorList>
<person name="Lebrun J.J."/>
<person name="Takabe K."/>
<person name="Chen Y."/>
<person name="Vale W."/>
</authorList>
<dbReference type="PubMed" id="9892009"/>
<dbReference type="DOI" id="10.1210/mend.13.1.0218"/>
</citation>
<scope>INTERACTION WITH ACVR1B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="2789" last="2801">
<title>The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.</title>
<authorList>
<person name="Hocevar B.A."/>
<person name="Smine A."/>
<person name="Xu X.X."/>
<person name="Howe P.H."/>
</authorList>
<dbReference type="PubMed" id="11387212"/>
<dbReference type="DOI" id="10.1093/emboj/20.11.2789"/>
</citation>
<scope>INTERACTION WITH DAB2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="18243" last="18248">
<title>Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription.</title>
<authorList>
<person name="Leong G.M."/>
<person name="Subramaniam N."/>
<person name="Figueroa J."/>
<person name="Flanagan J.L."/>
<person name="Hayman M.J."/>
<person name="Eisman J.A."/>
<person name="Kouzmenko A.P."/>
</authorList>
<dbReference type="PubMed" id="11278756"/>
<dbReference type="DOI" id="10.1074/jbc.m010815200"/>
</citation>
<scope>INTERACTION WITH SNW1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Nat. Cell Biol." volume="3" first="587" last="595">
<title>TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.</title>
<authorList>
<person name="Bonni S."/>
<person name="Wang H.R."/>
<person name="Causing C.G."/>
<person name="Kavsak P."/>
<person name="Stroschein S.L."/>
<person name="Luo K."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="11389444"/>
<dbReference type="DOI" id="10.1038/35078562"/>
</citation>
<scope>INTERACTION WITH SMURF2</scope>
<scope>MUTAGENESIS OF 221-PRO--TYR-225</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Biochem. J." volume="362" first="643" last="649">
<title>Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.</title>
<authorList>
<person name="Abdel-Wahab N."/>
<person name="Wicks S.J."/>
<person name="Mason R.M."/>
<person name="Chantry A."/>
</authorList>
<dbReference type="PubMed" id="11879191"/>
<dbReference type="DOI" id="10.1042/0264-6021:3620643"/>
</citation>
<scope>PHOSPHORYLATION AT SER-240</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="41361" last="41368">
<title>Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase.</title>
<authorList>
<person name="Funaba M."/>
<person name="Zimmerman C.M."/>
<person name="Mathews L.S."/>
</authorList>
<dbReference type="PubMed" id="12193595"/>
<dbReference type="DOI" id="10.1074/jbc.m204597200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-8; THR-220; SER-245; SER-250 AND SER-255</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="437" last="445">
<title>MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling.</title>
<authorList>
<person name="Lin F."/>
<person name="Morrison J.M."/>
<person name="Wu W."/>
<person name="Worman H.J."/>
</authorList>
<dbReference type="PubMed" id="15601644"/>
<dbReference type="DOI" id="10.1093/hmg/ddi040"/>
</citation>
<scope>INTERACTION WITH LEMD3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="15992" last="16001">
<title>The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-{beta} superfamily of cytokines.</title>
<authorList>
<person name="Pan D."/>
<person name="Estevez-Salmeron L.D."/>
<person name="Stroschein S.L."/>
<person name="Zhu X."/>
<person name="He J."/>
<person name="Zhou S."/>
<person name="Luo K."/>
</authorList>
<dbReference type="PubMed" id="15647271"/>
<dbReference type="DOI" id="10.1074/jbc.m411234200"/>
</citation>
<scope>INTERACTION WITH LEMD3</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Lab. Invest." volume="85" first="1330" last="1341">
<title>Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues.</title>
<authorList>
<person name="Arndt S."/>
<person name="Poser I."/>
<person name="Schubert T."/>
<person name="Moser M."/>
<person name="Bosserhoff A.-K."/>
</authorList>
<dbReference type="PubMed" id="16200078"/>
<dbReference type="DOI" id="10.1038/labinvest.3700344"/>
</citation>
<scope>INTERACTION WITH SKOR2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Cell" volume="125" first="915" last="928">
<title>PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.</title>
<authorList>
<person name="Lin X."/>
<person name="Duan X."/>
<person name="Liang Y.Y."/>
<person name="Su Y."/>
<person name="Wrighton K.H."/>
<person name="Long J."/>
<person name="Hu M."/>
<person name="Davis C.M."/>
<person name="Wang J."/>
<person name="Brunicardi F.C."/>
<person name="Shi Y."/>
<person name="Chen Y.G."/>
<person name="Meng A."/>
<person name="Feng X.H."/>
</authorList>
<dbReference type="PubMed" id="16751101"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.03.044"/>
</citation>
<scope>INTERACTION WITH PPM1A</scope>
<scope>DEPHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF VAL-398; SER-465 AND SER-467</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Cell" volume="125" first="929" last="941">
<title>Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.</title>
<authorList>
<person name="He W."/>
<person name="Dorn D.C."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Moore M.A."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="16751102"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.03.045"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH SMAD3 AND TRIM33</scope>
<scope>INTERACTION WITH TRIM33</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="39870" last="39880">
<title>The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.</title>
<authorList>
<person name="Simonsson M."/>
<person name="Kanduri M."/>
<person name="Gronroos E."/>
<person name="Heldin C.H."/>
<person name="Ericsson J."/>
</authorList>
<dbReference type="PubMed" id="17074756"/>
<dbReference type="DOI" id="10.1074/jbc.m607868200"/>
</citation>
<scope>ACETYLATION AT LYS-19</scope>
<scope>MUTAGENESIS OF LYS-19 AND LYS-20</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Nucleic Acids Res." volume="34" first="6314" last="6326">
<title>Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS.</title>
<authorList>
<person name="Sun Y."/>
<person name="Ding L."/>
<person name="Zhang H."/>
<person name="Han J."/>
<person name="Yang X."/>
<person name="Yan J."/>
<person name="Zhu Y."/>
<person name="Li J."/>
<person name="Song H."/>
<person name="Ye Q."/>
</authorList>
<dbReference type="PubMed" id="17099224"/>
<dbReference type="DOI" id="10.1093/nar/gkl914"/>
</citation>
<scope>INTERACTION WITH RBPMS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="12272" last="12289">
<title>3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins.</title>
<authorList>
<person name="Seong H.A."/>
<person name="Jung H."/>
<person name="Kim K.T."/>
<person name="Ha H."/>
</authorList>
<dbReference type="PubMed" id="17327236"/>
<dbReference type="DOI" id="10.1074/jbc.m609279200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY PDPK1</scope>
<scope>INTERACTION WITH PDPK1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Mol. Cell. Neurosci." volume="34" first="603" last="611">
<title>Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling.</title>
<authorList>
<person name="Arndt S."/>
<person name="Poser I."/>
<person name="Moser M."/>
<person name="Bosserhoff A.-K."/>
</authorList>
<dbReference type="PubMed" id="17292623"/>
<dbReference type="DOI" id="10.1016/j.mcn.2007.01.002"/>
</citation>
<scope>INTERACTION WITH SKOR1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="500" last="508">
<title>Smad3 is acetylated by p300/CBP to regulate its transactivation activity.</title>
<authorList>
<person name="Inoue Y."/>
<person name="Itoh Y."/>
<person name="Abe K."/>
<person name="Okamoto T."/>
<person name="Daitoku H."/>
<person name="Fukamizu A."/>
<person name="Onozaki K."/>
<person name="Hayashi H."/>
</authorList>
<dbReference type="PubMed" id="16862174"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209826"/>
</citation>
<scope>ACETYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="837" last="848">
<title>TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal.</title>
<authorList>
<person name="Varelas X."/>
<person name="Sakuma R."/>
<person name="Samavarchi-Tehrani P."/>
<person name="Peerani R."/>
<person name="Rao B.M."/>
<person name="Dembowy J."/>
<person name="Yaffe M.B."/>
<person name="Zandstra P.W."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="18568018"/>
<dbReference type="DOI" id="10.1038/ncb1748"/>
</citation>
<scope>INTERACTION WITH WWTR1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Dev. Cell" volume="16" first="345" last="357">
<title>Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling.</title>
<authorList>
<person name="Dai F."/>
<person name="Lin X."/>
<person name="Chang C."/>
<person name="Feng X.H."/>
</authorList>
<dbReference type="PubMed" id="19289081"/>
<dbReference type="DOI" id="10.1016/j.devcel.2009.01.022"/>
</citation>
<scope>INTERACTION WITH RANBP3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 465-SER--SER-467</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="3334" last="3344">
<title>SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.</title>
<authorList>
<person name="Takahata M."/>
<person name="Inoue Y."/>
<person name="Tsuda H."/>
<person name="Imoto I."/>
<person name="Koinuma D."/>
<person name="Hayashi M."/>
<person name="Ichikura T."/>
<person name="Yamori T."/>
<person name="Nagasaki K."/>
<person name="Yoshida M."/>
<person name="Matsuoka M."/>
<person name="Morishita K."/>
<person name="Yuki K."/>
<person name="Hanyu A."/>
<person name="Miyazawa K."/>
<person name="Inazawa J."/>
<person name="Miyazono K."/>
<person name="Imamura T."/>
</authorList>
<dbReference type="PubMed" id="19049980"/>
<dbReference type="DOI" id="10.1074/jbc.m808989200"/>
</citation>
<scope>INTERACTION WITH PRDM16</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="123" last="134">
<title>TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.</title>
<authorList>
<person name="Watanabe Y."/>
<person name="Itoh S."/>
<person name="Goto T."/>
<person name="Ohnishi E."/>
<person name="Inamitsu M."/>
<person name="Itoh F."/>
<person name="Satoh K."/>
<person name="Wiercinska E."/>
<person name="Yang W."/>
<person name="Shi L."/>
<person name="Tanaka A."/>
<person name="Nakano N."/>
<person name="Mommaas A.M."/>
<person name="Shibuya H."/>
<person name="Ten Dijke P."/>
<person name="Kato M."/>
</authorList>
<dbReference type="PubMed" id="20129061"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.10.028"/>
</citation>
<scope>INTERACTION WITH PMEPA1</scope>
<scope>MUTAGENESIS OF TRP-368</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8; SER-458 AND SER-460</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Cell Biol. Int." volume="35" first="1153" last="1157">
<title>ZNF580, a novel C2H2 zinc-finger transcription factor, interacts with the TGF-beta signal molecule Smad2.</title>
<authorList>
<person name="Luo Y."/>
<person name="Hu W."/>
<person name="Xu R."/>
<person name="Hou B."/>
<person name="Zhang L."/>
<person name="Zhang W."/>
</authorList>
<dbReference type="PubMed" id="21599657"/>
<dbReference type="DOI" id="10.1042/cbi20110050"/>
</citation>
<scope>INTERACTION WITH ZNF580</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="1368" last="1375">
<title>USP15 is a deubiquitylating enzyme for receptor-activated SMADs.</title>
<authorList>
<person name="Inui M."/>
<person name="Manfrin A."/>
<person name="Mamidi A."/>
<person name="Martello G."/>
<person name="Morsut L."/>
<person name="Soligo S."/>
<person name="Enzo E."/>
<person name="Moro S."/>
<person name="Polo S."/>
<person name="Dupont S."/>
<person name="Cordenonsi M."/>
<person name="Piccolo S."/>
</authorList>
<dbReference type="PubMed" id="21947082"/>
<dbReference type="DOI" id="10.1038/ncb2346"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP15</scope>
<scope>DNA-BINDING</scope>
<scope>INTERACTION WITH USP15</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Cell. Signal." volume="24" first="1999" last="2006">
<title>Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-beta pathway.</title>
<authorList>
<person name="Bruce D.L."/>
<person name="Macartney T."/>
<person name="Yong W."/>
<person name="Shou W."/>
<person name="Sapkota G.P."/>
</authorList>
<dbReference type="PubMed" id="22781750"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2012.07.003"/>
</citation>
<scope>INTERACTION WITH PPP5C</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8 AND SER-458</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Mol. Cell" volume="49" first="1147" last="1158">
<title>CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.</title>
<authorList>
<person name="Abbas T."/>
<person name="Mueller A.C."/>
<person name="Shibata E."/>
<person name="Keaton M."/>
<person name="Rossi M."/>
<person name="Dutta A."/>
</authorList>
<dbReference type="PubMed" id="23478445"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.02.003"/>
</citation>
<scope>PHOSPHORYLATION AT SER-465 AND SER-467</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="2072" last="2083">
<title>Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-beta signaling.</title>
<authorList>
<person name="Feng Y."/>
<person name="Wu H."/>
<person name="Xu Y."/>
<person name="Zhang Z."/>
<person name="Liu T."/>
<person name="Lin X."/>
<person name="Feng X.H."/>
</authorList>
<dbReference type="PubMed" id="24324267"/>
<dbReference type="DOI" id="10.1074/jbc.m113.526905"/>
</citation>
<scope>INTERACTION WITH ZNF451</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH ZNF451; SMAD3 AND SMAD4</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="12680" last="12692">
<title>C18 ORF1, a novel negative regulator of transforming growth factor-beta signaling.</title>
<authorList>
<person name="Nakano N."/>
<person name="Maeyama K."/>
<person name="Sakata N."/>
<person name="Itoh F."/>
<person name="Akatsu R."/>
<person name="Nakata M."/>
<person name="Katsu Y."/>
<person name="Ikeno S."/>
<person name="Togawa Y."/>
<person name="Vo Nguyen T.T."/>
<person name="Watanabe Y."/>
<person name="Kato M."/>
<person name="Itoh S."/>
</authorList>
<dbReference type="PubMed" id="24627487"/>
<dbReference type="DOI" id="10.1074/jbc.m114.558981"/>
</citation>
<scope>INTERACTION WITH LDLRAD4</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1998" name="Annu. Rev. Biochem." volume="67" first="753" last="791">
<title>TGF-beta signal transduction.</title>
<authorList>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9759503"/>
<dbReference type="DOI" id="10.1146/annurev.biochem.67.1.753"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1999" name="Cytokine Growth Factor Rev." volume="10" first="187" last="199">
<title>Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.</title>
<authorList>
<person name="Verschueren K."/>
<person name="Huylebroeck D."/>
</authorList>
<dbReference type="PubMed" id="10647776"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00012-x"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2000" name="Cytokine Growth Factor Rev." volume="11" first="5" last="13">
<title>The Smad pathway.</title>
<authorList>
<person name="Wrana J.L."/>
<person name="Attisano L."/>
</authorList>
<dbReference type="PubMed" id="10708948"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00024-6"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2000" name="Cytokine Growth Factor Rev." volume="11" first="15" last="22">
<title>TGF-beta signaling by Smad proteins.</title>
<authorList>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="10708949"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00025-8"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2014" name="J. Signal Transduct." volume="2014" first="970346" last="970346">
<title>TGF-beta signaling cooperates with AT motif-binding factor-1 for repression of the alpha -fetoprotein promoter.</title>
<authorList>
<person name="Sakata N."/>
<person name="Kaneko S."/>
<person name="Ikeno S."/>
<person name="Miura Y."/>
<person name="Nakabayashi H."/>
<person name="Dong X.Y."/>
<person name="Dong J.T."/>
<person name="Tamaoki T."/>
<person name="Nakano N."/>
<person name="Itoh S."/>
</authorList>
<dbReference type="PubMed" id="25105025"/>
<dbReference type="DOI" id="10.1155/2014/970346"/>
</citation>
<scope>INTERACTION WITH ZFHX3</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2000" name="Science" volume="287" first="92" last="97">
<title>Structural basis of Smad2 recognition by the Smad anchor for receptor activation.</title>
<authorList>
<person name="Wu G."/>
<person name="Chen Y.-G."/>
<person name="Ozdamar B."/>
<person name="Gyuricza C.A."/>
<person name="Chong P.A."/>
<person name="Wrana J.L."/>
<person name="Massague J."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="10615055"/>
<dbReference type="DOI" id="10.1126/science.287.5450.92"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 261-456 IN COMPLEX WITH ZFYVE9</scope>
<scope>INTERACTION WITH SARA</scope>
<scope>MUTAGENESIS OF ASN-381</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2004" name="Mol. Cell" volume="15" first="813" last="823">
<title>Structural basis of heteromeric smad protein assembly in TGF-beta signaling.</title>
<authorList>
<person name="Chacko B.M."/>
<person name="Qin B.Y."/>
<person name="Tiwari A."/>
<person name="Shi G."/>
<person name="Lam S."/>
<person name="Hayward L.J."/>
<person name="De Caestecker M."/>
<person name="Lin K."/>
</authorList>
<dbReference type="PubMed" id="15350224"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.07.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 270-466 IN COMPLEX WITH SMAD4</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-300</scope>
</reference>
<comment type="function">
<text evidence="25 27 32 35 52">Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.</text>
</comment>
<comment type="subunit">
<text evidence="12 15 16 17 18 21 22 23 24 25 26 30 31 32 33 34 35 36 37 38 39 41 42 43 46 49 50 51 52">Monomer; the absence of TGF-beta. Heterodimer; in the presence of TGF-beta. Forms a heterodimer with co-SMAD, SMAD4, in the nucleus to form the transactivation complex SMAD2/SMAD4. Interacts with AIP1, HGS, PML and WWP1 (By similarity). Interacts with NEDD4L in response to TGF-beta (By similarity). Found in a complex with SMAD3 and TRIM33 upon addition of TGF-beta. Interacts with ACVR1B, SMAD3 and TRIM33. Interacts (via the MH2 domain) with ZFYVE9; may form trimers with the SMAD4 co-SMAD. Interacts with FOXH1, homeobox protein TGIF, PEBP2-alpha subunit, CREB-binding protein (CBP), EP300, SKI and SNW1. Interacts with SNON; when phosphorylated at Ser-465/467. Interacts with SKOR1 and SKOR2. Interacts with PRDM16. Interacts (via MH2 domain) with LEMD3. Interacts with RBPMS. Interacts with WWP1. Interacts (dephosphorylated form, via the MH1 and MH2 domains) with RANBP3 (via its C-terminal R domain); the interaction results in the export of dephosphorylated SMAD3 out of the nucleus and termination of the TGF-beta signaling. Interacts with PDPK1 (via PH domain). Interacts with DAB2; the interactions are enhanced upon TGF-beta stimulation. Interacts with USP15. Interacts with PPP5C. Interacts with ZNF580. Interacts with LDLRAD4 (via the SMAD interaction motif). Interacts (via MH2 domain) with PMEPA1 (via the SMAD interaction motif). Interacts with ZFHX3. Interacts with ZNF451 (PubMed:24324267). Identified in a complex that contains at least ZNF451, SMAD2, SMAD3 and SMAD4 (PubMed:24324267). Interacts weakly with ZNF8 (By similarity). Interacts (when phosphorylated) with RNF111; RNF111 acts as an enhancer of the transcriptional responses by mediating ubiquitination and degradation of SMAD2 inhibitors (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-2691178">
<id>Q12955</id>
<label>ANK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-712619">
<id>P05060</id>
<label>CHGB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-1171238">
<id>P98082</id>
<label>DAB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-2695893">
<id>Q9BZ29</id>
<label>DOCK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-1759806">
<id>O75593</id>
<label>FOXH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-852823">
<id>P05412</id>
<label>JUN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-1052346">
<id>Q9NYA4</id>
<label>MTMR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-1105035">
<id>P07197</id>
<label>NEFM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-3867416">
<id>Q8TAK6</id>
<label>OLIG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-989143">
<id>P35813</id>
<label>PPM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-992681">
<id>Q9H6Z4</id>
<label>RANBP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-446668">
<id>P61586</id>
<label>RHOA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-347281">
<id>P12755</id>
<label>SKI</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-347161">
<id>P84022</id>
<label>SMAD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-347263">
<id>Q13485</id>
<label>SMAD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-396727">
<id>Q9HAU4</id>
<label>SMURF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-632715">
<id>Q13573</id>
<label>SNW1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-2337775">
<id>Q9H3D4</id>
<label>TP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-2214398">
<id>Q9UPN9</id>
<label>TRIM33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-743923">
<id>O00308</id>
<label>WWP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-2513582">
<id>Q96KR1</id>
<label>ZFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-296817">
<id>O95405</id>
<label>ZFYVE9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1040141">
<id>Q15796</id>
</interactant>
<interactant intactId="EBI-9969973">
<id>P70056</id>
<label>foxh1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="25 35 51">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25 35 37 39 51">Nucleus</location>
</subcellularLocation>
<text evidence="25 35 51">Cytoplasmic and nuclear in the absence of TGF-beta. On TGF-beta stimulation, migrates to the nucleus when complexed with SMAD4 (PubMed:9865696). On dephosphorylation by phosphatase PPM1A, released from the SMAD2/SMAD4 complex, and exported out of the nucleus by interaction with RANBP1 (PubMed:16751101, PubMed:19289081).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q15796-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q15796-2</id>
<name>Short</name>
<name>Smad2Deltaexon3</name>
<sequence type="described" ref="VSP_006178"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="37">Expressed at high levels in skeletal muscle, endothelial cells, heart and placenta.</text>
</comment>
<comment type="PTM">
<text evidence="19 20 32 40 45 46 47 48">Phosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases. TGF-beta-induced Ser-465/467 phosphorylation declines progressively in a KMT5A-dependent manner. Able to interact with SMURF2 when phosphorylated on Ser-465/467, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin. Phosphorylated by PDPK1.</text>
</comment>
<comment type="PTM">
<text evidence="12 38">In response to TGF-beta, ubiquitinated by NEDD4L; which promotes its degradation. Monoubiquitinated, leading to prevent DNA-binding (By similarity). Deubiquitination by USP15 alleviates inhibition and promotes activation of TGF-beta target genes (PubMed:21947082). Ubiquitinated by RNF111, leading to its degradation: only SMAD2 proteins that are 'in use' are targeted by RNF111, RNF111 playing a key role in activating SMAD2 and regulating its turnover (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="27 29 53">Acetylated on Lys-19 by coactivators in response to TGF-beta signaling, which increases transcriptional activity. Isoform short: Acetylation increases DNA binding activity in vitro and enhances its association with target promoters in vivo. Acetylation in the nucleus by EP300 is enhanced by TGF-beta.</text>
</comment>
<comment type="similarity">
<text evidence="54">Belongs to the dwarfin/SMAD family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SMAD2ID370.html"/>
</comment>
<dbReference type="EMBL" id="U59911">
<property type="protein sequence ID" value="AAC50789.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U68018">
<property type="protein sequence ID" value="AAB17087.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U65019">
<property type="protein sequence ID" value="AAB17054.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF027964">
<property type="protein sequence ID" value="AAC51918.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U78733">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78727">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78728">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78729">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78730">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78731">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78732">
<property type="protein sequence ID" value="AAC39657.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014840">
<property type="protein sequence ID" value="AAH14840.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025699">
<property type="protein sequence ID" value="AAH25699.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11934.1">
<molecule id="Q15796-1"/>
</dbReference>
<dbReference type="PIR" id="S71797">
<property type="entry name" value="S71797"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001003652.1">
<molecule id="Q15796-1"/>
<property type="nucleotide sequence ID" value="NM_001003652.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005892.1">
<molecule id="Q15796-1"/>
<property type="nucleotide sequence ID" value="NM_005901.5"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005258316.1">
<molecule id="Q15796-1"/>
<property type="nucleotide sequence ID" value="XM_005258259.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006722514.1">
<molecule id="Q15796-1"/>
<property type="nucleotide sequence ID" value="XM_006722451.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016881234.1">
<molecule id="Q15796-1"/>
<property type="nucleotide sequence ID" value="XM_017025745.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016881235.1">
<molecule id="Q15796-2"/>
<property type="nucleotide sequence ID" value="XM_017025746.1"/>
</dbReference>
<dbReference type="PDB" id="1DEV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/C=261-456"/>
</dbReference>
<dbReference type="PDB" id="1KHX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=241-467"/>
</dbReference>
<dbReference type="PDB" id="1U7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/C=270-467"/>
</dbReference>
<dbReference type="PDB" id="2LB3">
<property type="method" value="NMR"/>
<property type="chains" value="B=217-224"/>
</dbReference>
<dbReference type="PDB" id="5XOD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=262-458"/>
</dbReference>
<dbReference type="PDB" id="5ZOJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B/C=262-458"/>
</dbReference>
<dbReference type="PDBsum" id="1DEV"/>
<dbReference type="PDBsum" id="1KHX"/>
<dbReference type="PDBsum" id="1U7V"/>
<dbReference type="PDBsum" id="2LB3"/>
<dbReference type="PDBsum" id="5XOD"/>
<dbReference type="PDBsum" id="5ZOJ"/>
<dbReference type="BMRB" id="Q15796"/>
<dbReference type="SASBDB" id="Q15796"/>
<dbReference type="SMR" id="Q15796"/>
<dbReference type="BioGRID" id="110262">
<property type="interactions" value="285"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1">
<property type="entry name" value="SMAD2-SMAD3-SMAD4 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-11">
<property type="entry name" value="SMAD2 homotrimer"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3208">
<property type="entry name" value="SMAD2-SMAD4 complex"/>
</dbReference>
<dbReference type="CORUM" id="Q15796"/>
<dbReference type="DIP" id="DIP-29716N"/>
<dbReference type="IntAct" id="Q15796">
<property type="interactions" value="226"/>
</dbReference>
<dbReference type="MINT" id="Q15796"/>
<dbReference type="STRING" id="9606.ENSP00000262160"/>
<dbReference type="ChEMBL" id="CHEMBL2396512"/>
<dbReference type="DrugBank" id="DB04522">
<property type="generic name" value="Dexfosfoserine"/>
</dbReference>
<dbReference type="iPTMnet" id="Q15796"/>
<dbReference type="PhosphoSitePlus" id="Q15796"/>
<dbReference type="BioMuta" id="SMAD2"/>
<dbReference type="DMDM" id="13633914"/>
<dbReference type="EPD" id="Q15796"/>
<dbReference type="jPOST" id="Q15796"/>
<dbReference type="MassIVE" id="Q15796"/>
<dbReference type="PaxDb" id="Q15796"/>
<dbReference type="PeptideAtlas" id="Q15796"/>
<dbReference type="PRIDE" id="Q15796"/>
<dbReference type="ProteomicsDB" id="60764">
<molecule id="Q15796-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60765">
<molecule id="Q15796-2"/>
</dbReference>
<dbReference type="ABCD" id="Q15796">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="9235">
<property type="antibodies" value="1874 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4087"/>
<dbReference type="Ensembl" id="ENST00000262160">
<molecule id="Q15796-1"/>
<property type="protein sequence ID" value="ENSP00000262160"/>
<property type="gene ID" value="ENSG00000175387"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000356825">
<molecule id="Q15796-2"/>
<property type="protein sequence ID" value="ENSP00000349282"/>
<property type="gene ID" value="ENSG00000175387"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402690">
<molecule id="Q15796-1"/>
<property type="protein sequence ID" value="ENSP00000384449"/>
<property type="gene ID" value="ENSG00000175387"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000586040">
<molecule id="Q15796-2"/>
<property type="protein sequence ID" value="ENSP00000466193"/>
<property type="gene ID" value="ENSG00000175387"/>
</dbReference>
<dbReference type="GeneID" id="4087"/>
<dbReference type="KEGG" id="hsa:4087"/>
<dbReference type="UCSC" id="uc010xdc.4">
<molecule id="Q15796-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4087"/>
<dbReference type="DisGeNET" id="4087"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000175387.15"/>
<dbReference type="GeneCards" id="SMAD2"/>
<dbReference type="GeneReviews" id="SMAD2"/>
<dbReference type="HGNC" id="HGNC:6768">
<property type="gene designation" value="SMAD2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000175387">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601366">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15796"/>
<dbReference type="OpenTargets" id="ENSG00000175387"/>
<dbReference type="PharmGKB" id="PA134959722"/>
<dbReference type="eggNOG" id="KOG3701">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153499"/>
<dbReference type="HOGENOM" id="CLU_026736_0_2_1"/>
<dbReference type="InParanoid" id="Q15796"/>
<dbReference type="KO" id="K04500"/>
<dbReference type="OMA" id="PNNTEYN"/>
<dbReference type="PhylomeDB" id="Q15796"/>
<dbReference type="TreeFam" id="TF314923"/>
<dbReference type="PathwayCommons" id="Q15796"/>
<dbReference type="Reactome" id="R-HSA-1181150">
<property type="pathway name" value="Signaling by NODAL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1502540">
<property type="pathway name" value="Signaling by Activin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173788">
<property type="pathway name" value="Downregulation of TGF-beta receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173789">
<property type="pathway name" value="TGF-beta receptor signaling activates SMADs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173795">
<property type="pathway name" value="Downregulation of SMAD2/3:SMAD4 transcriptional activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173796">
<property type="pathway name" value="SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3304356">
<property type="pathway name" value="SMAD2/3 Phosphorylation Motif Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3311021">
<property type="pathway name" value="SMAD4 MH2 Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3315487">
<property type="pathway name" value="SMAD2/3 MH2 Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656532">
<property type="pathway name" value="TGFBR1 KD Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-452723">
<property type="pathway name" value="Transcriptional regulation of pluripotent stem cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9615017">
<property type="pathway name" value="FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617828">
<property type="pathway name" value="FOXO-mediated transcription of cell cycle genes"/>
</dbReference>
<dbReference type="SignaLink" id="Q15796"/>
<dbReference type="SIGNOR" id="Q15796"/>
<dbReference type="BioGRID-ORCS" id="4087">
<property type="hits" value="7 hits in 897 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SMAD2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q15796"/>
<dbReference type="GeneWiki" id="Mothers_against_decapentaplegic_homolog_2"/>
<dbReference type="GenomeRNAi" id="4087"/>
<dbReference type="Pharos" id="Q15796">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q15796"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 18"/>
</dbReference>
<dbReference type="RNAct" id="Q15796">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000175387">
<property type="expression patterns" value="Expressed in calcaneal tendon and 245 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q15796">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15796">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0032444">
<property type="term" value="C:activin responsive factor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071144">
<property type="term" value="C:heteromeric SMAD protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071141">
<property type="term" value="C:SMAD protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070410">
<property type="term" value="F:co-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070411">
<property type="term" value="F:I-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019902">
<property type="term" value="F:phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070412">
<property type="term" value="F:R-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048156">
<property type="term" value="F:tau protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005160">
<property type="term" value="F:transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034713">
<property type="term" value="F:type I transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032924">
<property type="term" value="P:activin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030325">
<property type="term" value="P:adrenal gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009952">
<property type="term" value="P:anterior/posterior pattern specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045165">
<property type="term" value="P:cell fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007182">
<property type="term" value="P:common-partner SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048617">
<property type="term" value="P:embryonic foregut morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001706">
<property type="term" value="P:endoderm formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007369">
<property type="term" value="P:gastrulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030073">
<property type="term" value="P:insulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001707">
<property type="term" value="P:mesoderm formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038092">
<property type="term" value="P:nodal signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035265">
<property type="term" value="P:organ growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031016">
<property type="term" value="P:pancreas development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048340">
<property type="term" value="P:paraxial mesoderm morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060039">
<property type="term" value="P:pericardium development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030513">
<property type="term" value="P:positive regulation of BMP signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900224">
<property type="term" value="P:positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031053">
<property type="term" value="P:primary miRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051098">
<property type="term" value="P:regulation of binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017015">
<property type="term" value="P:regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070723">
<property type="term" value="P:response to cholesterol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0062009">
<property type="term" value="P:secondary palate development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0023019">
<property type="term" value="P:signal transduction involved in regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007183">
<property type="term" value="P:SMAD protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060395">
<property type="term" value="P:SMAD protein signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007352">
<property type="term" value="P:zygotic specification of dorsal/ventral axis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="DisProt" id="DP01319"/>
<dbReference type="Gene3D" id="2.60.200.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00127"/>
<dbReference type="InterPro" id="IPR013790">
<property type="entry name" value="Dwarfin"/>
</dbReference>
<dbReference type="InterPro" id="IPR003619">
<property type="entry name" value="MAD_homology1_Dwarfin-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR013019">
<property type="entry name" value="MAD_homology_MH1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017855">
<property type="entry name" value="SMAD-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001132">
<property type="entry name" value="SMAD_dom_Dwarfin-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036578">
<property type="entry name" value="SMAD_MH1_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13703">
<property type="entry name" value="PTHR13703"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03165">
<property type="entry name" value="MH1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03166">
<property type="entry name" value="MH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00523">
<property type="entry name" value="DWA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00524">
<property type="entry name" value="DWB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56366">
<property type="entry name" value="SSF56366"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51075">
<property type="entry name" value="MH1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51076">
<property type="entry name" value="MH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="6 7 8 9 53">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Mothers against decapentaplegic homolog 2" id="PRO_0000090852">
<location>
<begin position="2"/>
<end position="467"/>
</location>
</feature>
<feature type="domain" description="MH1" evidence="13">
<location>
<begin position="10"/>
<end position="176"/>
</location>
</feature>
<feature type="domain" description="MH2" evidence="14">
<location>
<begin position="274"/>
<end position="467"/>
</location>
</feature>
<feature type="short sequence motif" description="PY-motif">
<location>
<begin position="221"/>
<end position="225"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="11">
<location>
<position position="74"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="11">
<location>
<position position="149"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="11">
<location>
<position position="161"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="11">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="6 7 8 9 53">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK3" evidence="5 7 10 20">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="55">
<location>
<position position="220"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CAMK2" evidence="14 19">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="55">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="55">
<location>
<position position="250"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="55">
<location>
<position position="255"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 7 10">
<location>
<position position="458"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="460"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 46">
<location>
<position position="464"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TGFBR1" evidence="14 40 46 47 48">
<location>
<position position="465"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TGFBR1" evidence="14 40 46 47 48">
<location>
<position position="467"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_006178" evidence="54">
<location>
<begin position="79"/>
<end position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal carcinoma sample." id="VAR_011375" evidence="45">
<original>R</original>
<variation>C</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036473" evidence="28">
<original>D</original>
<variation>V</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal carcinoma sample." id="VAR_011376" evidence="44">
<location>
<begin position="344"/>
<end position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal carcinoma sample." id="VAR_011377" evidence="45">
<original>L</original>
<variation>R</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal carcinoma sample." id="VAR_011378" evidence="45">
<original>P</original>
<variation>H</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal carcinoma sample." id="VAR_011379" evidence="45">
<original>D</original>
<variation>E</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on acetylation." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to SMURF2." evidence="18">
<location>
<begin position="221"/>
<end position="225"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PMEPA1." evidence="36">
<original>W</original>
<variation>A</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to SARA." evidence="15">
<original>N</original>
<variation>S</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased binding to PPM1A." evidence="25">
<original>V</original>
<variation>R</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by TGFBR1; when associated with A-465 and A-467." evidence="46">
<original>S</original>
<variation>A</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="mutagenesis site" description="Binds RANBP3." evidence="35">
<original>SMS</original>
<variation>AMA</variation>
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced RANBP2 binding." evidence="35">
<original>SMS</original>
<variation>DMD</variation>
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in binding to PPM1A. Loss of phosphorylation by TGFBR1; when associated with A-464 and A-467." evidence="25 46">
<original>S</original>
<variation>A</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in binding to PPM1A." evidence="25 46">
<original>S</original>
<variation>D</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in binding to PPM1A. Loss of phosphorylation by TGFBR1; when associated with A-464 and A-465." evidence="25 46">
<original>S</original>
<variation>A</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in binding to PPM1A." evidence="25 46">
<original>S</original>
<variation>D</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="264"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="274"/>
<end position="281"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="294"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="305"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="323"/>
<end position="329"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="330"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="336"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="344"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="351"/>
<end position="353"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="355"/>
<end position="358"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="360"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="381"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="387"/>
<end position="397"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="402"/>
<end position="406"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="407"/>
<end position="412"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="413"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="423"/>
<end position="427"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="431"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="434"/>
<end position="442"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="443"/>
<end position="453"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DEV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KHX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1U7V"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62432"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00438"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00439"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10615055"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278756"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11387212"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389444"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11879191"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12193595"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15350224"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15601644"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15647271"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16200078"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16751101"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16751102"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16862174"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17074756"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17099224"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17292623"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17327236"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18568018"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19049980"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19289081"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20129061"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21599657"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21947082"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22781750"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23478445"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24324267"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24627487"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25105025"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8673135"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8752209"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8980228"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9136927"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346908"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9670020"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9702198"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9865696"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9892009"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="54" type="ECO:0000305"/>
<evidence key="55" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12193595"/>
</source>
</evidence>
<sequence length="467" mass="52306" checksum="95406DB5FC0AA4C9" modified="1996-11-01" version="1">MSSILPFTPPVVKRLLGWKKSAGGSGGAGGGEQNGQEEKWCEKAVKSLVKKLKKTGRLDELEKAITTQNCNTKCVTIPSTCSEIWGLSTPNTIDQWDTTGLYSFSEQTRSLDGRLQVSHRKGLPHVIYCRLWRWPDLHSHHELKAIENCEYAFNLKKDEVCVNPYHYQRVETPVLPPVLVPRHTEILTELPPLDDYTHSIPENTNFPAGIEPQSNYIPETPPPGYISEDGETSDQQLNQSMDTGSPAELSPTTLSPVNHSLDLQPVTYSEPAFWCSIAYYELNQRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVNRNATVEMTRRHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQEFAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSVRCSSMS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

